ConductScience.org, home
Genes
API referenceFor AI assistants

Gene · 406907

MIR124-1: microRNA 124-1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR124-1: microRNA 124-1. Genes, record 406907. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406907

On this page

Gene

Symbol
MIR124-1
HGNC
Name
microRNA 124-1
HGNC
NCBI Gene ID
406907
NCBI Gene
HGNC ID
HGNC:31502
HGNC
Ensembl
ENSG00000284321
NCBI Gene
Aliases
MIR124A, MIR124A1, MIRN124-1, MIRN124A1, hsa-mir-124-1, hsa-mir-124a-1, mir-124-1
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants818

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR124-1 papersNewest fiscal year
P30CA016672Cancer Center Support Grant82025
P30CA093373Cancer Center Support Grant P3052025
P30CA016058Cancer Center Support Grant42025
P30CA134274UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT32025
P50CA127001SPORE in Brain Cancer32025
P20GM103436IDeA Networks of Biomedical Research Excellence in Kentucky22025
P30AI110527Tennessee Center for AIDS Research (TN-CFAR)22025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)22025
R01CA225958Novel bioengineered microRNA therapeutics for lung cancer22025
T32HL007171Translational Pulmonary Vascular Biology Program22025

1 to 10 of 818Source NIH's project files

See all 818 nih grants

Papers1,702

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Association of miR-499, miR-27a, and miR-34a Gene Polymorphisms With Susceptibility to Type 2 Diabetes Mellitus in an Iranian Population: A Case-Control Study.Biomed Res Int202642713823PubTator, text miningPubMed
Multifaceted roles of miR‑124 in cancer: Molecular mechanisms and clinical prospects (Review).Int J Oncol202641891957PubTator, text miningPubMed
Exploring Neuronal Exosome miRNAs as Biomarkers of Neuroinflammation and Neuroplasticity in Amateur Boxers After Repetitive Head Trauma.Mol Neurobiol202641832326PubTator, text miningPubMed
Epigenetic regulation in type II diabetes: linking molecular mechanisms to clinical management.J Diabetes Metab Disord202641767434PubTator, text miningPubMed
Next-Generation Biomarkers in Multiple Myeloma: Advancing Diagnosis, Risk Stratification, and Precision Therapy Beyond Current Guidelines.Pharmaceuticals (Basel)202641754860PubTator, text miningPubMed
Precision Oncology in Ocular Melanoma: Integrating Molecular and Liquid Biopsy Biomarkers.Curr Issues Mol Biol202641751395PubTator, text miningPubMed
Extracellular vesicles in rheumatoid arthritis: emerging roles in progression, diagnosis, and therapeutic development.Front Immunol202641743711PubTator, text miningPubMed
Exercise-derived extracellular vesicles in oncology: a new frontier for translational nanomedicine.J Transl Med202641606592PubTator, text miningPubMed
Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review).Int J Mol Med202641574706PubTator, text miningPubMed
Strong Association Between MiRNA Gene Variants and Type 2 Diabetes Mellitus in a Caucasian Population.Int J Mol Sci202541226486PubTator, text miningPubMed

1 to 10 of 1,702

See all 1,702 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/406907

GET https://conductscience.org/api/genes/v1/406907/grants?page=2

API referenceFor AI assistants